이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Recreational Football for Young-to-middle-aged Inactive Men

2026년 8월 31일 업데이트: Peter Krustrup, University of Southern Denmark

Euro Football Fitness - Recreational Football as a Broad-spectrum Health Intervention for 30-50-year-old Inactive Men

The aim of this study was to examine the health and physical fitness effects of 12 weeks of recreational football in inactive 30-50-year-old men. This was a two-arm, parallel-group randomized controlled trial with a 1:2 allocation ratio to either a control group, which was informed to maintain their inactive lifestyle, or an intervention group, which completed a 12-week recreational football-based exercise programme. Health and physical fitness assessments were performed at baseline and post-intervention (12 weeks) and selected training sessions throughout the intervention were monitored for internal and external load markers.

연구 개요

상세 설명

Randomization:

The participants were randomized 1:2 to the control or the intervention groups, respectively. Randomization was performed by a researcher not involved in data collection or outcome assessment. Blinding of participants and instructors, coaches and the investigation team leading the training sessions was not feasible in this type of exercise intervention. Outcome evaluators, who were not involved in intervention delivery or group allocation, were blinded to group assignment throughout the assessment time points (baseline and 12 weeks).

Statistical analysis:

Both intention-to-treat (ITT) and per-protocol (PP) approaches were applied. The ITT analysis included all randomized participants; missing post-intervention values were handled using multiple imputation. The PP analysis included only participants who attended ≥66% of the prescribed sessions. Descriptive statistics were calculated using observed data and are reported as mean ± SD. The distribution of continuous variables was inspected visually using histograms and Q-Q plots, and normality was further assessed using the Shapiro-Wilk test. Model assumptions were evaluated by visual inspection of residual plots and Q-Q plots of model residuals.

Outcome variables were analysed using linear mixed-effects models to account for repeated measurements within participants. For each outcome, Time (pre vs post), Group (intervention vs control), and the Time × Group interaction were specified as fixed effects, with a participant-specific random intercept to model within-subject clustering, according to the general form: outcome ~ Time + Group + Time × Group + (1 | participant). Fixed effects were evaluated using omnibus F-tests with Satterthwaite-approximated degrees of freedom, and model estimates are reported as regression coefficients (b) with standard errors and 95% confidence intervals. Where appropriate, post hoc pairwise comparisons of estimated marginal means were used to decompose significant effects, with multiplicity controlled using Bonferroni adjustment. Model fit was summarised using marginal and conditional R², and variance components were reported as random-intercept and residual variance. The intraclass correlation coefficient (ICC) was calculated to quantify the proportion of variance attributable to between-participant differences.

Effect sizes were expressed as partial eta squared (ηp²) for omnibus effects and Cohen's d for within- and between-group contrasts, using the standard deviation (SD), not the standard error, as the standardiser to avoid inflation (Lakens, 2013). Cohen's d was interpreted as trivial (<0.20), small (0.20-0.49), moderate (0.50-0.79), and large (≥0.80), following Cohen's conventional thresholds (Cohen, 1988). Partial eta squared was interpreted as small (ηp² ≈ 0.01), moderate (ηp² ≈ 0.06), and large (ηp² ≈ 0.14) (Richardson, 2011). These thresholds were used only as descriptive guidelines, and effects were interpreted alongside the magnitude and precision of the estimated mean differences. All tests were two-sided, with statistical significance set at α = 0.05. Statistical analyses were performed using jamovi (version 2.6.23; The jamovi project, Sydney, Australia) and R packages (R Core Team, R Foundation for Statistical Computing, Vienna, Austria) appropriate for each analysis.

To overcome the common limitation of low statistical power highlighted in previous recreational football interventions, a substantially larger sample size was deliberately recruited. This strategic design choice was undertaken not only to enhance the robustness of subgroup and ITT analyses but also to increase the precision of effect size estimates, thereby improving the generalizability of the findings.

연구 유형

중재적

등록 (실제)

300

단계

  • 해당 없음

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인

건강한 자원 봉사자를 받아들입니다

예

설명

Inclusion Criteria:

  • 30-50-year-old-males
  • inactive (i.e., not exercising for more than 20 min on three or more days per week)
  • with medical clearance from a physician to undertake moderate-to-vigorous intensity exercise

Exclusion Criteria:

  • Cardiovascular or cerebrovascular disease
  • Advanced retinopathy
  • Renal failure
  • Previous cardiovascular event

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 방지
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Experimental: Intervention group
Participants allocated to the intervention group undertook a 12-week recreational football-based exercise programme performed 2-3 times per week, with each session lasting 60 minutes, under the supervision of sports education graduates and the research team.
Participants allocated to the intervention group undertook a 12-week recreational football-based exercise programme performed 2-3 times per week, with each session lasting 60 minutes, under the supervision of sports education graduates and the research team.
다른 이름들:
  • Recreational football
간섭 없음: No Intervention: Control group
Participants allocated to the control group were informed to maintain their current lifestyle and physical activity habits for the duration of the study. No supervised exercise programme was provided by the research team during the 12-week intervention period. Following the 12-week assessments, the control group participants were offered the opportunity to participate in the recreational football programme.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Between-groups differences at 12 weeks in maximal oxygen uptake
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Maximal oxygen uptake (mL/min/kg) was measured by pulmonary gas exchange measurements. The participants performed an incremental treadmill test until voluntary exhaustion in a laboratory, according to a standardized incremental protocol.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]

2차 결과 측정

결과 측정
측정값 설명
기간
Between-groups differences at 12 weeks in systolic blood pressure
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Systolic blood pressure (mmHg) was measured in a laboratory by an automatic upper arm blood pressure monitor (multiparameter patient monitor, Omron Z207, Kyoto, Japan) according to standardized procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in diastolic blood pressure
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Diastolic blood pressure (mmHg) was measured using an automatic upper arm blood pressure monitor (multiparameter patient monitor, Omron Z207, Kyoto, Japan) according to standardized procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in resting heart rate
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Resting heart rate (bpm) was measured using an automatic upper arm blood pressure monitor (multiparameter patient monitor, Omron Z207, Kyoto, Japan) according to standardized procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in whole-body mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Whole-body mass was measured by a whole-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left arm total mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left arm total mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right arm total mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right arm total mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left leg total mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left leg total mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right leg total mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right leg total mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in gynoid total mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Gynoid total mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in android total mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Android total mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in whole-body fat mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Whole-body fat mass was measured by a whole-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left arm fat mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left arm fat mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right arm fat mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right arm fat mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left leg fat mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left leg fat mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right leg fat mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right leg fat mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in gynoid fat mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Gynoid fat mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in android fat mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Android fat mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in in whole-body lean mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Whole-body lean mass was measured by a whole-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left arm lean mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left arm lean mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right arm lean mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right arm lean mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left leg lean mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left leg lean mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right leg lean mass
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right leg lean mass was measured by a regional-body dual-energy X-ray absorptiometry following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in whole-body bone mineral density
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Whole-body bone mineral density was measured by dual-energy X-ray absorptiometry scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in whole-body bone mineral content
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Whole-body bone mineral content was measured by dual-energy X-ray absorptiometry scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in lumbar spine bone mineral density
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Lumbar spine bone mineral density was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in lumbar spine bone mineral content
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Lumbar spine bone mineral content was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in femur bone mineral density
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Femur bone mineral density was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in femur bone mineral content
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Femur bone mineral content was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left arm bone mineral density
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left arm mineral density was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left arm bone mineral content
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left arm bone mineral content was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right arm bone mineral density
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right arm bone mineral density was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right arm bone mineral content
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right arm mineral content was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left leg bone mineral density
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left leg bone mineral density was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in left leg bone mineral content
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Left leg bone mineral content was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right leg bone mineral density
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right leg bone mineral density was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in right leg bone mineral content
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Right leg mineral content was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in whole-body total T-score
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Whole-body total T-score was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in whole-body total Z-score
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Whole-body total Z-score was measured by dual-energy X-ray absorptiometry regional scans following standard procedures.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in procollagen type-1 amino-terminal propeptide
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Plasma concentrations of biochemical bone turnover markers were analysed by chemiluminescence method using a fully automated immunoassay system.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in osteocalcin
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Plasma concentrations of biochemical bone turnover markers were analysed by chemiluminescence method using a fully automated immunoassay system.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in carboxy-terminal type-1 collagen crosslinks
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Plasma concentrations of biochemical bone turnover markers were analysed by chemiluminescence method using a fully automated immunoassay system.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in postural balance
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Postural balance was evaluated by the number of falls in a single-legged flamingo balance test.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in aerobic performance
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Aerobic performance (Yo-Yo intermittent endurance level 2 test total distance covered (m)) was evaluated on a football artificial grass pitch, according to a standardized protocol.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in lower body muscle strength
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Lower body muscle strength (standing long jump distance (cm)) was evaluated on a football artificial grass pitch, according to a standardized protocol.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in neck circumference
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Neck circumference was evaluated according to a standardized protocol.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in waist circumference
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Waist circumference was evaluated according to a standardized protocol.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in total cholesterol
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Total cholesterol (mg/dl) was determined by an automated analyser.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in high-density lipoprotein cholesterol
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
High-density lipoprotein cholesterol (mg/dl) was determined by an automated analyser.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in low-density lipoprotein cholesterol
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Low-density lipoprotein cholesterol (mg/dl) was determined by an automated analyser.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in triglycerides
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Triglycerides (mg/dl) was determined by an automated analyser.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in glycosylated haemoglobin
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Glycosylated haemoglobin (%) was determined by an automated analyser.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in fasting blood glucose
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Fasting blood glucose (mg/dl) was determined by an automated analyser.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences at 12 weeks in fasting plasma insulin
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Fasting blood insulin (µmol/L) was determined was determined by an automated analyser.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Between-groups differences in physical activity levels
기간: [Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Physical activity levels were measured utilizing the international physical activity questionnaire - short form.
[Time Frame: Baseline and 12 weeks after the beginning of the intervention]
Mean and peak relative heart rate
기간: [Time Frame: 12 weeks]
Mean and peak relative heart rate were measured for selected participants in the intervention group during selected training sessions of the exercise programme.
[Time Frame: 12 weeks]
Mean and peak absolute heart rate
기간: [Time Frame: 12 weeks]
Mean and peak absolute heart rate were measured for selected participants in the intervention group during selected training sessions of the exercise programme.
[Time Frame: 12 weeks]
Time (absolute and relative) spent in heart rate zones
기간: [Time Frame: 12 weeks]
Time (absolute and relative) spent in heart rate zones were measured for selected participants in the intervention group during selected training sessions of the exercise programme.
[Time Frame: 12 weeks]
Edwards TRIMP
기간: [Time Frame: 12 weeks]
Edwards TRIMP (AU) was determined for selected participants in the intervention group during selected training sessions of the exercise programme.
[Time Frame: 12 weeks]
Matches total distance covered
기간: [Time Frame: 12 weeks]
Matches total distance covered was measured for selected participants in the intervention group during selected training sessions matches of the exercise programme
[Time Frame: 12 weeks]
Match accelerations
기간: [Time Frame: 12 weeks]
Accelerations performed were measured for selected participants in the intervention group during selected training sessions matches of the exercise programme
[Time Frame: 12 weeks]
Match decelerations
기간: [Time Frame: 12 weeks]
Match decelerations performed were measured for selected participants in the intervention group selected training sessions matches of the exercise programme
[Time Frame: 12 weeks]
Matches rating of perceived exertion
기간: [Time Frame: 12 weeks]
Rating of perceived exertion was measured for selected participants in the intervention group during selected training sessions matches of the exercise programme
[Time Frame: 12 weeks]
Fun scores
기간: [Time Frame: 12 weeks]
Fun scores were measured for selected participants in the intervention group during selected training sessions matches of the exercise programme
[Time Frame: 12 weeks]
Blood lactate
기간: [Time Frame: 12 weeks]
Blood lactate values were measured for selected participants in the intervention group during selected training sessions matches of the exercise programme
[Time Frame: 12 weeks]
Delayed Onset Muscle Soreness
기간: [Time Frame: 12 weeks]
Delayed Onset Muscle Soreness was measured for selected participants in the intervention group during the exercise programme
[Time Frame: 12 weeks]
Harms
기간: [Time Frame: 12 weeks]
Harms occurring during the exercise programme were registered.
[Time Frame: 12 weeks]
Attendance
기간: [Time Frame: 12 weeks]
Number and percentage of scheduled exercise sessions attended by each participant during the exercise programme.
[Time Frame: 12 weeks]

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2017년 1월 1일

기본 완료 (실제)

2017년 7월 31일

연구 완료 (실제)

2018년 7월 31일

연구 등록 날짜

최초 제출

2026년 8월 31일

QC 기준을 충족하는 최초 제출

2026년 8월 31일

처음 게시됨 (실제)

2026년 9월 4일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 4일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 8월 31일

마지막으로 확인됨

2026년 8월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

Participant data will not be publicly shared due to confidentiality reasons. Aggregate data supporting the findings of this study may be made available from the corresponding author upon reasonable request.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다